Publications

  • Clark, R., Coffee, N., Turner, D., Eckert, K., Smail, T., Stewart, S., et al. (2011). Can the Cardiac ARIA Index improve cardiac care for Australia's Indigenous population? In Heart, Lung and Circulation. Second CSANZ Indigenous Cardiovascular Health Conference. Alice Springs, Australia. Jun 2011, pp. s9-s10.
  • White, H.D., Tonkin, A.M., Simes, J., Stewart, R.A., Mann, K., Thompson, P.L., et al. (2014). Reply: The latest generation of troponin immunoassays: The "cholesterol" of the third millennium? Journal of The American College of Cardiology, 63(25) pp. 2884-2885.
  • Chellappah, J., Tonkin, A.M., Gregg, M.E.D., de Courten, M. and Reid, C.M. (2012). School food environment and nutrition policies in Southern Metropolitan schools in Melbourne. Australian and New Zealand Journal of Public Health, 36(6) pp. 584-584.
  • Woods, R.L., Nelson, M.R., Tonkin, A.M. and Reid, C.M. (2009). In reply. Medical Journal of Australia, 191(6) pp. 356-357.
  • Yallop, J., Clark, R., Chan, B., Croucher, J., Wilson, A., Sellar, B., et al. (2006). CHAT - a study of a nurse-led system of care. Australian Nursing Journal, 14(4) pp. 19.
  • Bunker, S., Tonkin, A.M., Hickie, I., Colquhoun, D., Heistaro, S.M. and Dunbar, J.A. (2005). Epidemiologists and researchers continue to overlook the obvious. British Medical Journal, 331(7521)
    [Web Link]
  • Jureidini, J.N. and Tonkin, A.M. (2003). Paroxetine in major depression (Letter to Editor) J. Am. Acad. Child Adolescent Psychiatry. 42 pp. 514-515.
    [10.1097/01.CHI.0000046825.95464.DA]
  • Jelinek, M., Santamaria, J.D., Best, J.D., Thompson, D.R., Tonkin, A.M. and Vale, M. (2014). Reversing social disadvantage in secondary prevention of coronary heart disease. International Journal of Cardiology, 171(3) pp. 346-350.
  • Hudson, H.M., Lo, S., Simes, J., Tonkin, A.M. and Heritier, S. (2014). Semiparametric methods for multistate survival models in randomised trials. STATISTICS IN MEDICINE, 33(10) pp. 1621-1645.
  • Zoungas, S., Curtis, A.J., Tonkin, A.M. and McNeil, J.J. (2014). Statins in the elderly: An answered question? Current Opinion in Cardiology, 29(4) pp. 372-380.
  • Zoungas, S., Curtis, A.J., McNeil, J.J. and Tonkin, A.M. (2014). Treatment of dyslipidemia and cardiovascular outcomes: The journey so far - Is this the end for statins? Clinical Pharmacology and Therapeutics, 96(2) pp. 192-205.
  • White, H.D., Tonkin, A.M., Simes, J., Stewart, R.A., Mann, K., Thompson, P.L., et al. (2014). Association of contemporary sensitive troponin i levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: Results from the LIPID study. Journal of The American College of Cardiology, 63(4) pp. 345-354.
  • Teng, T.K., Williams, T., Bremner, A.P., Tohira, H., Franklin, P.J., Tonkin, A.M., et al. (2014). A systematic review of air pollution and incidence of out-of-hospital cardiac arrest. Journal of Epidemiology and Community Health, 68(1) pp. 37-43.
  • Straney, L., Finn, J., Dennekamp, M.N., Bremner, A.P., Tonkin, A.M. and Jacobs, I. (2014). Evaluating the impact of air pollution on the incidence of out-of-hospital cardiac arrest in the Perth Metropolitan Region: 2000-2010. Journal of Epidemiology and Community Health, 68(1) pp. 6-12.
  • Funke-Kaiser, A., Mann, K., Colquhoun, D., Zeller, T., Hunt, D., Simes, J., et al. (2014). Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: The LIPID study. International Journal of Cardiology, 172(2) pp. 411-418.
  • Glasziou, P., Irwig, L.M., Kirby, A., Tonkin, A.M. and Simes, R.J. (2014). Which lipid measurement should we monitor? An analysis of the LIPID study. BMJ Open, 4(2)
  • Hopper, I., Samuel, R.A., Hayward, C.S., Tonkin, A.M. and Krum, H. (2014). Can medications be safely withdrawn in patients with stable chronic heart failure? systematic review and meta-analysis. JOURNAL OF CARDIAC FAILURE, 20(7) pp. 522-532.
  • Krum, H., Forbes, A., Yallop, J., Driscoll, A., Croucher, J., Chan, B., et al. (2013). Telephone support to rural and remote patients with heart failure: The Chronic Heart failure Assessment by Telephone (CHAT) study. Cardiovascular Therapeutics, 31(4) pp. 230-237.
    [10.1111/1755-5922.12009]
  • Grimm, R., McNeil, J.J., Applegate, W.B., Beilin, L.J., Espinoza, S., Johnston, C.I., et al. (2013). Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial. Contemporary Clinical Trials, 36(2) pp. 555-564.
  • Driscoll, A., Tonkin, A.M., Stewart, A.G., Worrall-Carter, L., Thompson, D.R., Riegel, B.J., et al. (2013). Complexity of management and health outcomes in a prospective cohort study of 573 heart failure patients in Australia: Does more equal less? Journal of Clinical Nursing, 22(11-12) pp. 1629-1638.
  • Driscoll, A., Beltrame, J.F., Beauchamp, A., Morgan, C., Weekes, A. and Tonkin, A.M. (2013). Reducing risk in coronary artery disease. Are Australian patients in general practice achieving targets? The coronary artery disease in general practice study (CADENCE) Internal Medicine Journal, 43(5) pp. 526-531.
  • Briffa, T. and Tonkin, A.M. (2013). Put disease prevention first. Circulation, 128(6) pp. 573-575.
  • Boekholdt, S.M., Arsenault, B.J., Hovingh, G.K., Mora, S., Pedersen, T., LaRosa, J.C., et al. (2013). Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: A meta-analysis. Circulation, 128(14) pp. 1504-1512.
  • Nestel, P., Barnes, E.H., Tonkin, A.M., Simes, J., Fournier, M., White, H.D., et al. (2013). Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease. Arteriosclerosis Thrombosis and Vascular Biology, 33(12) pp. 2902-2908.
  • White, H.D., Simes, J., Stewart, R.A., Blankenberg, S., Barnes, E.H., Marschner, I.C., et al. (2013). Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study. Journal of the American Heart Association, 2(5)
  • Kiropoulos, L.A., Meredith, I.T., Tonkin, A.M., Clarke, D., Antonis, P. and Plunkett, J.C. (2012). Psychometric properties of the cardiac depression scale in patients with coronary heart disease. BMC Psychiatry, 12(216)
  • Kiropoulos, L.A., Meredith, I.T., Tonkin, A.M., Clarke, D., Antonis, P. and Plunkett, J.C. (2012). Increased Psychosocial Stress in Greek-Born Immigrants Compared to Anglo-Australians with Coronary Heart Disease: The Healthy Heart, Healthy Mind Study. Heart, Lung and Circulation, 21(12) pp. 794-802.
  • Coffee, N., Turner, D., Clark, R., Eckert, K., Coombe, D., Hugo, G., et al. (2012). Measuring national accessibility to cardiac services using geographic information systems. Applied Geography, 34 pp. 445-455.
    [10.1016/j.apgeog.2012.01.007]
  • Clark, R., Coffee, N., Turner, D., Eckert, K., van Gaans, D., Wilkinson, D., et al. (2012). Application of geographic modeling techniques to quantify spatial access to health services before and after an acute cardiac event: The Cardiac Accessibility and Remoteness Index for Australia (ARIA) Project. Circulation, 125(16) pp. 2006-2014.
    [10.1161/CIRCULATIONAHA.111.083394]
  • Boekholdt, S.M., Arsenault, B.J., Mora, S., Pedersen, T., LaRosa, J.C., Nestel, P., et al. (2012). Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: A meta-analysis. JAMA-Journal of The American Medical Association, 307(12) pp. 1302-1309.
  • Linden, M.D., Tran, H.A., Woods, R.L. and Tonkin, A.M. (2012). High platelet reactivity and antiplatelet therapy resistance. Seminars in Thrombosis and Hemostasis, 38(2) pp. 200-212.
  • Watts, G.F., Sullivan, D., van Bockxmeer, F.M., Poplawski, N.K., Hamilton-Craig, I., Clifton, P.M., et al. (2012). A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology? Heart, Lung and Circulation, 21(9) pp. 543-550.
  • Tonkin, A.M., Hunt, D., Voysey, M., Kesaniemi, A.Y., Hamer, A.W., Waites, J.H., et al. (2012). Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. American Heart Journal, 163(3) pp. 508-514.
  • Tonkin, A.M. and Watts, G.F. (2012). Into the future: Diversifying lipid management. Lancet, 380(9858) pp. 1971-1974.
  • Roberts, M.A., Pilmore, H.L., Tonkin, A.M., Garg, A.X., Pascoe, E.M., Badve, S.V., et al. (2012). Challenges in blood pressure measurement in patients treated with maintenance hemodialysis. American Journal of Kidney Diseases, 60(3) pp. 463-472.
  • Reid, C.M., Storey, E., Wong, T.Y., Woods, R.L., Tonkin, A.M., Wang, J.J., et al. (2012). Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neurovascular imaging study (ENVIS-ion) BMC Neurology, 12(3)
  • Ranasinghe, I., Turnbull, F., Tonkin, A., Clark, R., Coffee, N. and Brieger, D. (2012). Comparative effectiveness of population interventions to improve access to reperfusion for ST-segment-elevation myocardial infarction in Australia. Circulation: Cardiovascular Quality and Outcomes, 5(4) pp. 429-436.
    [10.1161/CIRCOUTCOMES.112.965111]
  • Peiris, D.P., Brown, A.D.H., Howard, M.P., Rickards, B.A., Tonkin, A.M., Ring, I.T., et al. (2012). Building better systems of care for Aboriginal and Torres Strait Islander people: Findings from the Kanyini health systems assessment. BMC Health Services Research, 12(1)
  • Nelson, M.R., Ramsay, E.N., Ryan, P., Willson, K., Tonkin, A.M., Wing, L.M., et al. (2012). A score for the prediction of cardiovascular events in the hypertensive aged. American Journal of Hypertension, 25(2) pp. 190-194.
    [10.1038/ajh.2011.192]
  • Mihaylova, B., Emberson, J., Blackwell, L., Keech, A.C., Simes, J., Barnes, E.H., et al. (2012). The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials. Lancet, 380(9841) pp. 581-590.
  • Ashton, E.L., Windebank, E., Skiba, M.A., Reid, C.M., Schneider, H., Rosenfeldt, F.L., et al. (2011). Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study. International Journal of Cardiology, 146(3) pp. 404-407.
  • Astley, C., Tonkin, A.M., Mahar, L.J., Davidson, P., Boyden, A., Brieger, D., et al. (2011). Clinical effectiveness in everyday practice: improving outcomes for all patients through a national acute coronary syndrome data collaborative. Internal Medicine Journal, 41(2) pp. 206-210.
    [10.1111/j.1445-5994.2010.02415.x] [Scopus]
  • Badve, S.V., Roberts, M.A., Hawley, C.M., Cass, A., Garg, A.X., Krum, H., et al. (2011). Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis. Journal of The American College of Cardiology, 58(11) pp. 1152-1161.
  • Beauchamp, A., Tonkin, A.M., Kelsall, H.L., Sundararajan, V., English, D., Sundaresan, L., et al. (2011). Validation of de-identified record linkage to ascertain hospital admissions in a cohort study. BMC Medical Research Methodology, 11(42)
  • Peeters, A., Nusselder, W.J., Stevenson, C.E., Boyko, E.J., Moon, L. and Tonkin, A.M. (2011). Age-specific trends in cardiovascular mortality rates in the Netherlands between 1980 and 2009. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 26(5) pp. 369-373.
  • McNeil, J.J. and Tonkin, A.M. (2011). The MAGIC study and the gastrointestinal effects of low-dose aspirin : Editorial to: "prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: Rationale and design of the MAGIC study" CARDIOVASCULAR DRUGS AND THERAPY, 25(6) pp. 503-504.
  • Watts, G.F., Sullivan, D., Poplawski, N.K., van Bockxmeer, F.M., Hamilton-Craig, I., Clifton, P.M., et al. (2011). Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements, 12(2) pp. 221-263.
  • Driscoll, A., Tonkin, A.M., Stewart, A.G., Thompson, D.R., Worrall-Carter, L., Riegel, B.J., et al. (2011). Development of an evidence-based scoring system (HF-IS) to assess the quality of heart failure programmes for patients postdischarge from hospital. Journal of Clinical Nursing, 20(21-22) pp. 3011-3019.
  • Driscoll, A., Krum, H., Wolfe, R. and Tonkin, A.M. (2011). Nurse-led titration of ?-adrenoreceptor blocking agents in chronic heart failure patients in the community. JOURNAL OF CARDIAC FAILURE, 17(3) pp. 224-230.
  • Driscoll, A., Beauchamp, A., Lyubomirsky, G., Demos, L.L., McNeil, J.J. and Tonkin, A.M. (2011). Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women. Internal Medicine Journal, 41(10) pp. 730-736.
  • Chen, L., Magliano, D., Balkau, B., Wolfe, R., Brown, L., Tonkin, A.M., et al. (2011). Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: The AusDiab study. Diabetic Medicine, 28(4) pp. 414-423.
  • Briffa, T., Nedkoff, L.J., Peeters, A., Tonkin, A.M., Hung, J., Ridout, S.C., et al. (2011). Discordant age and sex-specific trends in the incidence of a first coronary heart disease event in Western Australia from 1996 to 2007. Heart, 97(5) pp. 400-404.
  • Briffa, T., Hobbs, M.S.T., Tonkin, A.M., Sanfilippo, F.M., Hickling, S.C., Ridout, S.C., et al. (2011). Population trends of recurrent coronary heart disease event rates remain high. Circulation: Cardiovascular Quality and Outcomes, 4(1) pp. 107-113.
  • Harriss, L., Ajani, A.E., Hunt, D., Shaw, J.A., Chambers, B.R., Dewey, H.M., et al. (2011). Accuracy of national mortality codes in identifying adjudicated cardiovascular deaths. Australian and New Zealand Journal of Public Health, 35(5) pp. 466-476.
  • Barr, E.L.M., Cameron, A.J., Balkau, B., Zimmet, P., Welborn, T.A., Tonkin, A.M., et al. (2010). HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study. Diabetologia, 53(1) pp. 79-88.
  • Beauchamp, A., Peeters, A., Tonkin, A.M. and Turrell, G. (2010). Best practice for prevention and treatment of cardiovascular disease through an equity lens: A review. European Journal of Cardiovascular Prevention and Rehabilitation, 17(5) pp. 599-606.
  • Beauchamp, A., Peeters, A., Wolfe, R., Turrell, G., Harriss, L., Giles, G., et al. (2010). Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factors. Journal of Epidemiology and Community Health, 64(6) pp. 542-548.
  • Brown, A.D.H., Brieger, D., Tonkin, A.M., White, H.D., Walsh, W.F., Ridell, T., et al. (2010). Coronary Disease in Indigenous Populations: Summary from the CSANZ Indigenous Cardiovascular Health Conference. Heart, Lung and Circulation, 19(5-6) pp. 299-305.
  • Brown, A.D.H., Tonkin, A.M., White, H.D., Ridell, T., Brieger, D., Walsh, W.F., et al. (2010). The Cardiac Society Inaugural Cardiovascular Health Conference. Conference Findings and Ways Forward. Heart, Lung and Circulation, 19(5-6) pp. 264-268.
  • Cameron, A.J., Sicree, R.A., Zimmet, P., Alberti, K.G.M.M., Tonkin, A.M., Balkau, B., et al. (2010). Cut-points for waist circumference in Europids and South Asians. Obesity, 18(10) pp. 2039-2046.
  • Chen, L., Magliano, D., Balkau, B., Colagiuri, S., Zimmet, P., Tonkin, A.M., et al. (2010). AUSDRISK: An Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Medical Journal of Australia, 192(4) pp. 197-202.
  • Cui, J.S., Forbes, A., Kirby, A., Marschner, I.C., Simes, J., Hunt, D., et al. (2010). Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study. BMC Medical Research Methodology, 10(27)
  • Dennekamp, M.N., Akram, M., Abramson, M.J., Tonkin, A.M., Sim, M., Fridman, M., et al. (2010). Outdoor air pollution as a trigger for out-of-hospital cardiac arrests. Epidemiology, 21(4) pp. 494-500.
  • Hill, S.J., Spink, J.D., Cadilhac, D.A., Edwards, A.G.K., Kaufman, C.A., Rogers, S.L., et al. (2010). Absolute risk representation in cardiovascular disease prevention: Comprehension and preferences of health care consumers and general practitioners involved in a focus group study. BMC Public Health, 10(108)
  • Jeremy, R.W., Tonkin, A.M., White, H.D., Ridell, T., Brieger, D., Walsh, W.F., et al. (2010). Improving Cardiovascular Care for Indigenous Populations. Heart, Lung and Circulation, 19(5-6) pp. 344-350.
  • Kritharides, L., Brown, A.D.H., Brieger, D., Ridell, T., Zeitz, C.J., Jeremy, R.W., et al. (2010). Overview and Determinants of Cardiovascular Disease in Indigenous Populations. Heart, Lung and Circulation, 19(5-6) pp. 337-343.
  • Kritharides, L., Brown, A.D.H., Brieger, D., Ridell, T., Zeitz, C.J., Jeremy, R.W., et al. (2010). Recommendations Arising from the Inaugural CSANZ Conference on Indigenous Cardiovascular Health. Heart, Lung and Circulation, 19(5-6) pp. 269-272.
  • Liu, H.M., Patel, A.A., Brown, A.D.H., Eades, S., Hayman, N.E., Jan, S., et al. (2010). Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: A randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk. BMC Public Health, 10(458)
  • Mark, D., Anstrom, K.J., McNulty, S., Flaker, G.C., Tonkin, A.M., Smith, W.M., et al. (2010). Quality of life effects of automatic external defibrillators in the home: Results from the Home Automatic External Defibrillator Trial (HAT) American Heart Journal, 159(4) pp. 627-634.
  • Nelson, M.R., Ryan, P., Tonkin, A.M., Ramsay, E.N., Willson, K., Wing, L.M., et al. (2010). Prediction of Cardiovascular Events in Subjects in the Second Australian National Blood Pressure Study. Hypertension, 56(1) pp. 44-48.
    [10.1161/HYPERTENSIONAHA.109.148007] [10.1161/HYPERTENSIONAHA.109.148007] [Scopus]
  • Rostambeigi, N., Shaw, J., Atkins, R.C., Ghanbarian, A., Cameron, A.J., Forbes, A., et al. (2010). Waist circumference has heterogeneous impact on development of diabetes in different populations: Longitudinal comparative study between Australia and Iran. Diabetes Research and Clinical Practice, 88(1) pp. 117-124.
  • Tonkin, A.M. and Chen, L. (2010). Effects of combination lipid therapy in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation, 122(8) pp. 850-852.
  • White, H.D., Walsh, W.F., Brown, A.D.H., Ridell, T., Tonkin, A.M., Jeremy, R.W., et al. (2010). Rheumatic Heart Disease in Indigenous Populations. Heart, Lung and Circulation, 19(5-6) pp. 273-281.
  • Driscoll, A., Worrall-Carter, L., Hare, D.L., Davidson, P., Riegel, B.J., Tonkin, A.M., et al. (2009). Evidence-based chronic heart failure management programs: Reality or myth? Quality and Safety in Health Care, 18(6) pp. 450-455.
  • Cui, J.S., Forbes, A., Kirby, A., Simes, J. and Tonkin, A.M. (2009). Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: The LIPID study. European Journal of Cardiovascular Prevention and Rehabilitation, 16(6) pp. 660-668.
  • Chen, L., Tonkin, A.M., Moon, L., Mitchell, P.G., Dobson, A., Giles, G., et al. (2009). Recalibration and validation of the SCORE risk chart in the Australian population: The AusSCORE chart. European Journal of Cardiovascular Prevention and Rehabilitation, 16(5) pp. 562-570.
  • Cameron, A.J., Dunstan, D.W., Owen, N., Zimmet, P., Barr, E.L.M., Tonkin, A.M., et al. (2009). Health and mortality consequences of abdominal obesity: Evidence from the AusDiab study. Medical Journal of Australia, 191(4) pp. 202-208.
  • Barr, E.L.M., Tonkin, A.M., Welborn, T.A. and Shaw, J. (2009). Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: The AusDiab study. Internal Medicine Journal, 39(1) pp. 49-53.
  • Barr, E.L.M., Boyko, E.J., Zimmet, P., Wolfe, R., Tonkin, A.M. and Shaw, J. (2009). Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: The Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia, 52(3) pp. 415-424.
  • Woods, R.L., Tonkin, A.M., Nelson, M.R., Britt, H. and Reid, C.M. (2009). Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes? Medical Journal of Australia, 190(11) pp. 614-615.
  • MacDonald, I.L., Sharpe, N. and Tonkin, A.M. (2009). Cardiovascular disease in Australia and New Zealand: Early origins, ethnic disparities, opportunities. European Heart Journal, 30(7) pp. 746-747.
  • Soderberg, S., Colquhoun, D., Keech, A.C., Yallop, J., Barnes, E.H., Pollicino, C., et al. (2009). Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: Results from the LIPID study. International Journal of Obesity, 33(1) pp. 123-130.
  • Tonkin, A.M. and Chen, L. (2009). Where on the Healthcare Continuum Should We Invest? The Case for Primary Care? Heart, Lung and Circulation, 18(2) pp. 108-113.
  • Tonkin, A.M., Beauchamp, A. and Stevenson, C.E. (2009). The importance of extinguishing secondhand smoke. Circulation, 120(4) pp. 1339-1341.
  • Tonkin, A.M., Boyden, A. and Colagiuri, S. (2009). Maximising the effectiveness and cost-effectiveness of cardiovascular disease prevention in the general population. Medical Journal of Australia, 191(6) pp. 300-302.
  • Freeman, M.S., Clark, D.J., Andrianopoulos, N., Duffy, S.J., Lim, H.S., Brennan, A., et al. (2009). Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Catheterization and Cardiovascular Interventions, 73(6) pp. 763-768.
  • Glasziou, P., Irwig, L.M., Heritier, S., Simes, J. and Tonkin, A.M. (2008). Monitoring cholesterol levels: measurement error or true change? Annals of Internal Medicine, 148(9) pp. 656-661.
  • Cui, J.S., Forbes, A., Kirby, A., Marschner, I.C., Simes, J., West, M.J., et al. (2008). Parametric conditional frailty models for recurrent cardiovascular events in the lipid study. Clinical Trials, 5(6) pp. 565-574.
  • Chen, L., Rogers, S.L., Colagiuri, S., Cadilhac, D.A., Mathew, T.H., Boyden, A., et al. (2008). How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000. Medical Journal of Australia, 189(6) pp. 319-322.
  • Cameron, A.J., Magliano, D., Zimmet, P., Welborn, T.A., Colagiuri, S., Tonkin, A.M., et al. (2008). The metabolic syndrome as a tool for predicting future diabetes: The AusDiab study. Journal of Internal Medicine, 264(2) pp. 177-186.
  • Bardy, G.H., Lee, K.L., Mark, D., Poole, J.E., Toff, W.D., Tonkin, A.M., et al. (2008). Rationale and design of the Home Automatic External Defibrillator Trial (HAT) American Heart Journal, 155(3) pp. 445-454.
  • Bardy, G.H., Lee, K.L., Mark, D., Poole, J.E., Toff, W.D., Tonkin, A.M., et al. (2008). Home use of automated external defibrillators for sudden cardiac arrest. New England Journal of Medicine, 358(17) pp. 1793-1804.
  • Myles, P.S., Smith, J.A., Knight, J.L., Cooper, D.J., Silbert, B., McNeil, J.J., et al. (2008). Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: Rationale and design. American Heart Journal, 155(2) pp. 224-230.
    [10.1016/j.ahj.2007.10.003] [10.1016/j.ahj.2007.10.003] [Scopus]
  • West, M.J., Nestel, P., Kirby, A., Schnabel, R.B., Sullivan, D., Simes, J., et al. (2008). The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. European Heart Journal, 29(7) pp. 923-931.
  • Stewart, R.A., North, F.M., Sharples, K.J., Simes, J., Tonkin, A.M. and White, H.D. (2008). Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: Findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study. New Zealand Medical Journal, 121(1269) pp. 11-23.
  • Nelson, M.R., Reid, C.M., Ames, D., Beilin, L.J., Donnan, G., Gibbs, P., et al. (2008). Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: Results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study. Medical Journal of Australia, 189(2) pp. 105-109.
  • Clark, R., Eckert, K., Stewart, S., Phillips, S., Yallop, J., Tonkin, A., et al. (2007). Rural and urban differentials in primary care management of chronic heart failure: new data from the CASE study. Medical Journal of Australia, 186(9) pp. 441-445.
  • Clark, R., Yallop, J., Piterman, L., Croucher, J., Tonkin, A., Stewart, S., et al. (2007). Adherence, adaptation and acceptance of elderly chronic heart failure patients to receiving healthcare via telephone-monitoring. European Journal of Heart Failure, 9(11) pp. 1104-1111.
    [10.1016/j.ejheart.2007.07.018]
  • Clark, R., Yallop, J., Wickett, D., Krum, H., Tonkin, A. and Stewart, S. (2006). Nursing sans frontieres: a three year case study of multistate registration to support nursing practice using information technology. Australian Journal of Advanced Nursing, 24(1) pp. 39-45.
  • Stocker, R., Pollicino, C., Gay, C.A., Nestel, P., Colquhoun, D., Whiting, M.J., et al. (2006). Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study. Atherosclerosis, 187(1) pp. 198-204.
    [10.1016/j.atherosclerosis.2005.09.004] [10.1016/j.atherosclerosis.2005.09.004] [Scopus]
  • Tonkin, A.M., Eckermann, S.D., White, H.D., Friedlander, D., Glasziou, P., Magnus, P., et al. (2006). Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study. American Heart Journal, 151(6) pp. 1305-1312.
    [10.1016/j.ahj.2005.07.014] [Scopus]
  • Yallop, J., Chan, B., Piterman, L., Tonkin, A., Forbes, A., Davidson, P., et al. (2006). The Chronic Heart-failure Assistance by Telephone (CHAT) Study: Assessment of telephone support for vulnerable patients with chronic disease. Asia Pacific Journal of Family Medicine, 5 pp. 2.
    [Web Link]
  • Glasziou, P., Eckermann, S.D., Mulray, S., Simes, R., Martin, A.J., Kirby, A., et al. (2002). Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: Is it cost-effective? Medical Journal of Australia, 177(8) pp. 428-434.
    [Scopus]
  • Tonkin, A. and Chew, D. (1999). How Can We Stratify Patients With Unstable Angina And Determine Optimal Therapy? Dialogues in Cardiovascular Medicine, 4(3) pp. 146-158.
    [Web Link]
  • Twidale, N., Rayner, T., Menadue, M., Cain, M., Tonkin, A. and Oliver, J. (1993). Atrial natriuretic factor release during rapid ventricular pacing: interplay between autonomic and hemodynamic stimulants. American Heart Journal, 125(6) pp. 1638-1644.
    [Web Link]
  • Funke-Kaiser, A., Mann, K., Colquhoun, D., Zeller, T., Hunt, D., Simes, J., et al. (2014). Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: The LIPID study. International Journal of Cardiology, 172(2) pp. 411-418.
  • Glasziou, P., Irwig, L.M., Kirby, A., Tonkin, A.M. and Simes, R.J. (2014). Which lipid measurement should we monitor? An analysis of the LIPID study. BMJ Open, 4(2)
  • Hopper, I., Samuel, R.A., Hayward, C.S., Tonkin, A.M. and Krum, H. (2014). Can medications be safely withdrawn in patients with stable chronic heart failure? systematic review and meta-analysis. JOURNAL OF CARDIAC FAILURE, 20(7) pp. 522-532.
  • Hudson, H.M., Lo, S., Simes, J., Tonkin, A.M. and Heritier, S. (2014). Semiparametric methods for multistate survival models in randomised trials. STATISTICS IN MEDICINE, 33(10) pp. 1621-1645.
  • Zoungas, S., Curtis, A.J., Tonkin, A.M. and McNeil, J.J. (2014). Statins in the elderly: An answered question? Current Opinion in Cardiology, 29(4) pp. 372-380.
  • Straney, L., Finn, J., Dennekamp, M.N., Bremner, A.P., Tonkin, A.M. and Jacobs, I. (2014). Evaluating the impact of air pollution on the incidence of out-of-hospital cardiac arrest in the Perth Metropolitan Region: 2000-2010. Journal of Epidemiology and Community Health, 68(1) pp. 6-12.
  • Teng, T.K., Williams, T., Bremner, A.P., Tohira, H., Franklin, P.J., Tonkin, A.M., et al. (2014). A systematic review of air pollution and incidence of out-of-hospital cardiac arrest. Journal of Epidemiology and Community Health, 68(1) pp. 37-43.
  • White, H.D., Tonkin, A.M., Simes, J., Stewart, R.A., Mann, K., Thompson, P.L., et al. (2014). Association of contemporary sensitive troponin i levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: Results from the LIPID study. Journal of The American College of Cardiology, 63(4) pp. 345-354.
  • Zoungas, S., Curtis, A.J., McNeil, J.J. and Tonkin, A.M. (2014). Treatment of dyslipidemia and cardiovascular outcomes: The journey so far - Is this the end for statins? Clinical Pharmacology and Therapeutics, 96(2) pp. 192-205.
  • Jelinek, M., Santamaria, J.D., Best, J.D., Thompson, D.R., Tonkin, A.M. and Vale, M. (2014). Reversing social disadvantage in secondary prevention of coronary heart disease. International Journal of Cardiology, 171(3) pp. 346-350.

Contact

Add to address book
Phone: -
Email:
Location: - (-)
Postal address: GPO Box 2100, Adelaide 5001, South Australia
MACO login

inspiring achievement